Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001104659-21-070551
Filing Date
2021-05-21
Accepted
2021-05-21 17:00:38
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B4 tm2117200d1_424b4.htm 424B4 363575
2 GRAPHIC tm2117200d1_424b4img01.jpg GRAPHIC 3804
  Complete submission text file 0001104659-21-070551.txt   370021
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-252625 | Film No.: 21949955
SIC: 2834 Pharmaceutical Preparations